Heart Failure in Women

Ileana L. Pina, Carol Buchter

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The incidence of congestive heart failure in the US population is increasing as more women and men survive with chronic hypertensive and atherosclerotic heart disease. Almost half the patients in the US with heart failure are women. Hypertension, diabetes mellitus, and cigarette smoking are all more potent risk factors for the development of heart failure in women than in men. Important differences in presentation and mortality explain gender differences in the clinical course of heart failure. Overall mortality is lower for women than for men with symptomatic heart failure. Some but not all of this difference can be explained by a lower rate of ischemic heart disease. Standard treatments for congestive heart failure, including angiotensin converting enzyme inhibitors and beta-blockers, have been shown to be equally efficacious in men and in women. Preliminary data on angiotensin II receptor blockers suggests equivalent benefit with further trial data awaited. Peripartum cardiomyopathy is a form of heart failure unique to women, occurring in the last stages of pregnancy or within 5 months after delivery. Approximately half of affected women regain normal ventricular function but for those who do not, the risk of recurrent symptomatic heart failure and mortality during subsequent pregnancies is high.

Original languageEnglish (US)
Pages (from-to)337-344
Number of pages8
JournalCardiology in Review
Volume11
Issue number6
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Heart Failure
Mortality
Peripartum Period
Pregnancy
Ventricular Function
Angiotensin Receptor Antagonists
Cardiomyopathies
Angiotensin-Converting Enzyme Inhibitors
Myocardial Ischemia
Heart Diseases
Diabetes Mellitus
Smoking
Hypertension
Incidence
Population

Keywords

  • ACE inhibitors
  • Beta blockers
  • Cardiomyopathy
  • Congestive heart failure
  • Gender differences
  • Peripartum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Failure in Women. / Pina, Ileana L.; Buchter, Carol.

In: Cardiology in Review, Vol. 11, No. 6, 11.2003, p. 337-344.

Research output: Contribution to journalArticle

Pina, IL & Buchter, C 2003, 'Heart Failure in Women', Cardiology in Review, vol. 11, no. 6, pp. 337-344. https://doi.org/10.1097/01.crd.0000087213.92777.a5
Pina, Ileana L. ; Buchter, Carol. / Heart Failure in Women. In: Cardiology in Review. 2003 ; Vol. 11, No. 6. pp. 337-344.
@article{a1c7d14bf29f44f29241a6449d631426,
title = "Heart Failure in Women",
abstract = "The incidence of congestive heart failure in the US population is increasing as more women and men survive with chronic hypertensive and atherosclerotic heart disease. Almost half the patients in the US with heart failure are women. Hypertension, diabetes mellitus, and cigarette smoking are all more potent risk factors for the development of heart failure in women than in men. Important differences in presentation and mortality explain gender differences in the clinical course of heart failure. Overall mortality is lower for women than for men with symptomatic heart failure. Some but not all of this difference can be explained by a lower rate of ischemic heart disease. Standard treatments for congestive heart failure, including angiotensin converting enzyme inhibitors and beta-blockers, have been shown to be equally efficacious in men and in women. Preliminary data on angiotensin II receptor blockers suggests equivalent benefit with further trial data awaited. Peripartum cardiomyopathy is a form of heart failure unique to women, occurring in the last stages of pregnancy or within 5 months after delivery. Approximately half of affected women regain normal ventricular function but for those who do not, the risk of recurrent symptomatic heart failure and mortality during subsequent pregnancies is high.",
keywords = "ACE inhibitors, Beta blockers, Cardiomyopathy, Congestive heart failure, Gender differences, Peripartum",
author = "Pina, {Ileana L.} and Carol Buchter",
year = "2003",
month = "11",
doi = "10.1097/01.crd.0000087213.92777.a5",
language = "English (US)",
volume = "11",
pages = "337--344",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Heart Failure in Women

AU - Pina, Ileana L.

AU - Buchter, Carol

PY - 2003/11

Y1 - 2003/11

N2 - The incidence of congestive heart failure in the US population is increasing as more women and men survive with chronic hypertensive and atherosclerotic heart disease. Almost half the patients in the US with heart failure are women. Hypertension, diabetes mellitus, and cigarette smoking are all more potent risk factors for the development of heart failure in women than in men. Important differences in presentation and mortality explain gender differences in the clinical course of heart failure. Overall mortality is lower for women than for men with symptomatic heart failure. Some but not all of this difference can be explained by a lower rate of ischemic heart disease. Standard treatments for congestive heart failure, including angiotensin converting enzyme inhibitors and beta-blockers, have been shown to be equally efficacious in men and in women. Preliminary data on angiotensin II receptor blockers suggests equivalent benefit with further trial data awaited. Peripartum cardiomyopathy is a form of heart failure unique to women, occurring in the last stages of pregnancy or within 5 months after delivery. Approximately half of affected women regain normal ventricular function but for those who do not, the risk of recurrent symptomatic heart failure and mortality during subsequent pregnancies is high.

AB - The incidence of congestive heart failure in the US population is increasing as more women and men survive with chronic hypertensive and atherosclerotic heart disease. Almost half the patients in the US with heart failure are women. Hypertension, diabetes mellitus, and cigarette smoking are all more potent risk factors for the development of heart failure in women than in men. Important differences in presentation and mortality explain gender differences in the clinical course of heart failure. Overall mortality is lower for women than for men with symptomatic heart failure. Some but not all of this difference can be explained by a lower rate of ischemic heart disease. Standard treatments for congestive heart failure, including angiotensin converting enzyme inhibitors and beta-blockers, have been shown to be equally efficacious in men and in women. Preliminary data on angiotensin II receptor blockers suggests equivalent benefit with further trial data awaited. Peripartum cardiomyopathy is a form of heart failure unique to women, occurring in the last stages of pregnancy or within 5 months after delivery. Approximately half of affected women regain normal ventricular function but for those who do not, the risk of recurrent symptomatic heart failure and mortality during subsequent pregnancies is high.

KW - ACE inhibitors

KW - Beta blockers

KW - Cardiomyopathy

KW - Congestive heart failure

KW - Gender differences

KW - Peripartum

UR - http://www.scopus.com/inward/record.url?scp=0242413948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242413948&partnerID=8YFLogxK

U2 - 10.1097/01.crd.0000087213.92777.a5

DO - 10.1097/01.crd.0000087213.92777.a5

M3 - Article

C2 - 14580303

AN - SCOPUS:0242413948

VL - 11

SP - 337

EP - 344

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 6

ER -